☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
ptc therapeutics
PTC Therapeutics Join Forces with Novartis to Develop PTC518 for Treating Huntington's Disease
December 3, 2024
PTC Therapeutics Reports the US FDA’s Accelerated Approval of its Gene Therapy for AADC Deficiency
November 14, 2024
PharmaShots Weekly Snapshots (March 20 - 24, 2023)
March 24, 2023
PTC Therapeutics’ Upstaza (eladocagene exuparvovec) Receives NICE Recommendation for the Treatment of AADC Deficiency
March 24, 2023
PharmaShots Weekly Snapshot (Aug 17 -21 2020)
August 21, 2020
PharmaShots Weekly Snapshot (May 04-08, 2020)
May 11, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.